Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women With Polycystic Ovary Syndrome

NCT02265861 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.

NCT NCT02265861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women With Polycystic Ovary Syndrome
Lead sponsor
Nanjing University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovary syndrome